AI assistant
Ocugen, Inc. — Director's Dealing 2019
Dec 16, 2019
32915_dirs_2019-12-16_df4cd23e-c870-495f-898c-e1146740d712.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-27
Reporting Person: Tammara Vijay (Vice President)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (right to buy) | $.46 | 2024-09-18 | Common Stock (18217) | Direct | |
| Stock Options (right to buy) | $2.94 | 2026-04-26 | Common Stock (7191) | Direct | |
| Stock Options (right to buy) | $7.56 | 2027-08-17 | Common Stock (7191) | Direct | |
| Stock Options (right to buy) | $7.56 | 2027-12-15 | Common Stock (7191) | Direct | |
| Stock Options (right to buy) | $12.18 | 2028-08-13 | Common Stock (2397) | Direct | |
| Stock Options (right to buy) | $13.52 | 2028-12-07 | Common Stock (9588) | Direct |
Footnotes
F1: 100% of the Stock Options became exercisable immediately.
F2: 4,794 Stock Options became exercisable immediately, and the remaining 2,397 Stock Options will become exercisable on August 17, 2020, subject to continued employment with Ocugen, Inc. (the "Company").
F3: 2,397 Stock Options became exercisable immediately, and the remaining 4,794 Stock Options will become exercisable 50% each on December 15, 2019 and December 14, 2020, subject to continued employment with Company through the applicable vesting date.
F4: 799 Stock Options became exercisable immediately, and the remaining 1,598 Stock Options will become exercisable 50% each on July 23, 2020 and July 22, 2021, subject to continued employment with Company through the applicable vesting date.
F5: The Stock Options will become exercisable 1/3 each on December 7, 2019, December 7, 2020 and December 6, 2021, subject to continued employment with Company through the applicable vesting date.